Literature DB >> 15857736

Use of opioids in a Danish population-based cohort of cancer patients.

Lene Jarlbaek1, Morten Andersen, Jesper Hallas, Gerda Engholm, Jakob Kragstrup.   

Abstract

Until recently, Denmark has had the highest use of strong opioids per capita in the world. Our aim was to analyze cancer patients' use of opioids in this population by linkage between the Danish Cancer Register and a prescription database. The changes in opioid use from 1994 to 1998 in the entire cohort of cancer patients (n=24,190) in a Danish county (n approximately 470,000) were analyzed. The overall consumption of opioids increased from 20 kg to 37 kg oral morphine equivalents (omeq) per year. The average consumption increased from 7.6 to 10.7 g omeq/opioid user/year. The annual proportion of users increased from 17% to 20%. The proportion of patients who were alive 2 years after their first opioid prescription increased from 38% to 55%. Increased awareness towards pain treatment, with earlier initiation of opioid treatment and higher doses to the cancer patients, could be major explanations for the increase in the cancer patients' use of opioids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857736     DOI: 10.1016/j.jpainsymman.2004.07.010

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  11 in total

1.  Cancer patients' first treatment episode with opioids: a pharmaco-epidemiological perspective.

Authors:  Lene Jarlbaek; Jesper Hallas; Jakob Kragstrup; Morten Andersen
Journal:  Support Care Cancer       Date:  2005-09-27       Impact factor: 3.603

2.  Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data.

Authors:  Ingrid Schubert; Peter Ihle; Rainer Sabatowski
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

3.  Using a morphine equivalence metric to quantify opioid consumption: examining the capacity to provide effective treatment of debilitating pain at the global, regional, and country levels.

Authors:  Aaron M Gilson; Martha A Maurer; Karen M Ryan; Paul J Rathouz; James F Cleary
Journal:  J Pain Symptom Manage       Date:  2012-09-24       Impact factor: 3.612

4.  Opioids and breast cancer recurrence: A Danish population-based cohort study.

Authors:  Deirdre P Cronin-Fenton; Uffe Heide-Jørgensen; Thomas P Ahern; Timothy L Lash; Peer M Christiansen; Bent Ejlertsen; Per Sjøgren; Henrik Kehlet; Henrik T Sørensen
Journal:  Cancer       Date:  2015-07-24       Impact factor: 6.860

5. 

Authors:  Manon Videau; Maxime Thibault; Denis Lebel; Suzanne Atkinson; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2020-04-01

6.  Insufficient pain control for patients with cancer and dementia during terminal cancer stages.

Authors:  Wei-Hung Hsu; Jyh-Gang Hsieh; Ying-Wei Wang; Chia-Jung Hsieh; Huang-Ren Lin; Szu-Yuan Wu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

7.  Trends and characteristics of pethidine use in Taiwan: a six-year-long survey.

Authors:  Hsueh-Hsing Pan; Chung-Yi Li; Tso-Chou Lin; Ju-O Wang; Shung-Tai Ho; Kwua-Yun Wang
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

8.  Trends of Opioid Utilisation in Denmark: A Nationwide Study.

Authors:  Søren Kabell Nissen; Anton Pottegård; Jesper Ryg
Journal:  Drugs Real World Outcomes       Date:  2019-12

9.  Opioid Use at End-Of-Life Among Nova Scotia Patients With Cancer.

Authors:  Laura V Minard; Judith Fisher; Larry Broadfield; Gordon Walsh; Ingrid Sketris
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

10.  Effect of preoperative gabapentin and acetaminophen on opioid consumption in video-assisted thoracoscopic surgery: a retrospective study.

Authors:  Robert Qiu; Albert C Perrino; Holly Zurich; Nitin Sukumar; Feng Dai; Wanda Popescu
Journal:  Rom J Anaesth Intensive Care       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.